Pacira Aims For Non-Opioid Pipeline Growth With Flexion Buy

Deal Worth About $427.5m Upfront

Film x-ray knee joint with arthritis
Pacira is acquiring Flexion in a deal worth about $427.5m • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business